Report cover image

AI in Precision Medicine Market - 2025-2033

Published Mar 26, 2026
Length 200 Pages
SKU # DTAM21123959

Description

AI in Precision Medicine Market Overview:
The AI in Precision Medicine Market was valued at US$ 2.76 Billion in 2025 and is anticipated to reach US$ 16.95 Billion by 2033, at a CAGR of 0.2488 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the AI in Precision Medicine Market.

This report delivers a comprehensive overview of the AI in Precision Medicine Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding AI in Precision Medicine Market. The AI in Precision Medicine Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2025–2033.

AI in Precision Medicine Market Scope:
Key Players
• IBM Corporation

Major Highlights
This report delivers a comprehensive overview of the AI in Precision Medicine Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding AI in Precision Medicine Market. The AI in Precision Medicine Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2025–2033.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
South America (Colombia, Brazil, Argentina, Rest of South America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification
Increase Your Customer Base by 3X using our Partner Identification tool
Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

200 Pages
1. Market Introduction and Scope
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. Executive Insights and Key Takeaways
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Technology
2.4. Snippet by Component
2.5. Snippet by Application
2.6. Snippet by Region
3. Dynamics
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Advancements in AI Technologies
3.1.1.2. Rising Demand for Personalized Medicine
3.1.1.3. XX
3.1.2. Restraints
3.1.2.1. Data Privacy and Security Concerns
3.1.2.2. High Costs Associated with the Implementation of AI-Driven Precision Medicine
3.1.2.3. XX
3.1.3. Opportunity
4. Integration of Real-World Data
4.1. XX
4.1.1. Impact Analysis
5. Strategic Insights and Industry Outlook
5.1. Market Leaders and Pioneers
5.1.1. Emerging Pioneers and Prominent Players
5.1.2. Established leaders with the largest-selling Brand
5.1.3. Market leaders with established Product
5.2. CXO Perspectives
5.3. Latest Developments and Breakthroughs
5.4. Regulatory and Reimbursement Landscape
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. South America
5.4.5. Middle East & Africa
5.5. Porter’s Five Forces Analysis
5.6. Supply Chain Analysis
5.7. Patent Analysis
5.8. SWOT Analysis
5.9. Unmet Needs and Gaps
5.10. Recommended Strategies for Market Entry and Expansion
5.11. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
5.12. Pricing Analysis and Price Dynamics
5.13. Key Opinion Leaders
6. Global AI in Precision Medicine Market, By Technology
6.1. Introduction
6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Technology
6.1.2. Market Attractiveness Index, By Technology
6.2. Deep Learning*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Querying Method
6.4. Natural Language Processing
6.5. Context-Aware Processing
7. Global AI in Precision Medicine Market, By Component
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
7.1.2. Market Attractiveness Index, By Component
7.2. Hardware*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Software
7.4. Services
8. Global AI in Precision Medicine Market, By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Oncology*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Cardiology
8.4. Neurology
8.5. Respiratory
8.6. Others
9. Global AI in Precision Medicine Market, By Regional Market Analysis and Growth Opportunities
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. U.K.
9.3.6.3. France
9.3.6.4. Spain
9.3.6.5. Italy
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. South Korea
9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10. Competitive Landscape and Market Positioning
10.1. Competitive Overview and Key Market Players
10.2. Market Share Analysis and Positioning Matrix
10.3. Strategic Partnerships, Mergers & Acquisitions
10.4. Key Developments in Product Portfolios and Innovations
10.5. Company Benchmarking
11. Company Profiles
11.1. IBM Corporation*
11.1.1. Company Overview
11.1.1.1. Product Portfolio
11.1.1.2. Product Description
11.1.1.3. Product Key Performance Indicators (KPIs)
11.1.1.4. Historic and Forecasted Product Sales
11.1.1.5. Product Sales Volume
11.1.2. Financial Overview
11.1.2.1. Company Revenue
11.1.2.2. Geographical Revenue Shares
11.1.2.3. Revenue Forecasts
11.1.3. Key Developments
11.1.3.1. Mergers & Acquisitions
11.1.3.2. Key Product Development Activities
11.1.3.3. Regulatory Approvals, etc.
11.1.3.4. SWOT Analysis
11.1.4. IBM
11.1.5. Microsoft
11.1.6. Alphabet
11.1.7. Amazon Web Services
11.1.8. Tempus AI
11.1.9. Illumina
11.1.10. NVIDIA
11.1.11. IQVIA
11.1.12. BenevolentAI
11.1.13. Insilico Medicine
11.1.14. Emerging Players
11.1.14.1. Exscientia
11.1.14.2. Insilico Medicine
11.1.14.3. TEMPUS
11.1.14.4. BenevolentAI
11.1.14.5. PathAI, Inc.
11.1.14.6. Guardant Health, Inc. (*LIST NOT EXHAUSTIVE)
12. Assumptions and Research Methodology
12.1. Data Collection Methods
12.2. Data Triangulation
12.3. Forecasting Techniques
12.4. Data Verification and Validation
13. Appendix
13.1. About Us and Services
13.2. Contact Us
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.